AstraZenca Pharma India Ltd. | ASTRAZEN | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of AstraZenca Pharma India Ltd.



ASTRAZEN
AstraZenca Pharma India Ltd.

Rs. 3345.45
20-Mar-2023

5 Yr Performance

1 Yr Performance

Valuation

Quarterly

Earnings Yield


Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.